1. Home
  2. LXRX vs DDD Comparison

LXRX vs DDD Comparison

Compare LXRX & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • DDD
  • Stock Information
  • Founded
  • LXRX 1995
  • DDD 1986
  • Country
  • LXRX United States
  • DDD United States
  • Employees
  • LXRX N/A
  • DDD N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • DDD Computer peripheral equipment
  • Sector
  • LXRX Health Care
  • DDD Technology
  • Exchange
  • LXRX Nasdaq
  • DDD Nasdaq
  • Market Cap
  • LXRX 428.8M
  • DDD 360.4M
  • IPO Year
  • LXRX 2000
  • DDD N/A
  • Fundamental
  • Price
  • LXRX $1.52
  • DDD $3.16
  • Analyst Decision
  • LXRX Buy
  • DDD Buy
  • Analyst Count
  • LXRX 5
  • DDD 2
  • Target Price
  • LXRX $3.23
  • DDD $5.00
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • DDD 4.5M
  • Earning Date
  • LXRX 11-11-2025
  • DDD 11-25-2025
  • Dividend Yield
  • LXRX N/A
  • DDD N/A
  • EPS Growth
  • LXRX N/A
  • DDD N/A
  • EPS
  • LXRX N/A
  • DDD N/A
  • Revenue
  • LXRX $58,432,000.00
  • DDD $413,342,000.00
  • Revenue This Year
  • LXRX $67.21
  • DDD N/A
  • Revenue Next Year
  • LXRX N/A
  • DDD $1.78
  • P/E Ratio
  • LXRX N/A
  • DDD N/A
  • Revenue Growth
  • LXRX 1504.83
  • DDD N/A
  • 52 Week Low
  • LXRX $0.28
  • DDD $1.32
  • 52 Week High
  • LXRX $2.18
  • DDD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 70.28
  • DDD 72.25
  • Support Level
  • LXRX $1.28
  • DDD $2.80
  • Resistance Level
  • LXRX $1.42
  • DDD $3.29
  • Average True Range (ATR)
  • LXRX 0.10
  • DDD 0.27
  • MACD
  • LXRX 0.02
  • DDD 0.03
  • Stochastic Oscillator
  • LXRX 81.00
  • DDD 72.29

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: